Evidence map›Paper›PMID 29375727›Full record

ArticleBiomicrofluidics2018

An

Shuo Wang, Andrew Bruning, Oju Jeon, Fei Long, Eben Alsberg, Chang Kyoung Choi

Abstract read
In one paragraph

Article in Biomicrofluidics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shuo WangDepartment of Mechanical Engineering-Engineering Mechanics, Michigan Technological University, Houghton, Michigan 49931, USA.
Andrew BruningDepartment of Mechanical Engineering-Engineering Mechanics, Michigan Technological University, Houghton, Michigan 49931, USA.
Oju JeonDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio 44106, USA.
Fei LongDepartment of Mechanical Engineering-Engineering Mechanics, Michigan Technological University, Houghton, Michigan 49931, USA.
Eben Alsberg
Chang Kyoung ChoiDepartment of Mechanical Engineering-Engineering Mechanics, Michigan Technological University, Houghton, Michigan 49931, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alginate microgels are widely generated by ionic crosslinking methods, but this method has limitations in controlling the microgel degradation and generating non-spherical microgels. By employing oxidized methacrylated alginate (OMA) that is degradable and photocrosslinkable, we have successfully photocrosslinked monodisperse OMA microgels and demonstrated the feasibility to generate discoid alginate microgels. However, several technical issues obstructed our opto-microfluidic method from being a useful technique. Here, we further characterized and optimized this method. Monodisperse discoid OMA microgels with good shape consistency were, for the first time, generated. The curability of OMA microgels was characterized as the macromer concentration varied from 2% to 10%, and the minimum required photoinitiator (VA-086) concentrations were determined. The effects of crosslinking density and the presence of ions in the storage solution on swelling of OMA hydrogels were identified to give insights into accurate controlling of the microgel size. A much quicker degradation rate (within three weeks) compared to ionically crosslinked alginate hydrogels was indirectly identified by quantifying the elastic modulus using atomic force microscopy. The viability of encapsulated chondrocytes in OMA microgels formed by this method was higher than those from other existing methods, demonstrating its favorable cytocompatibility. It was found that the oxygen tension played a critical role in both the curability of microgels and the cytocompatibility of this technique. We also summarize common practical issues and provide related solutions and/or operational suggestions. By this method, OMA microgels are expected to be valuable alternatives to traditional ionically crosslinked alginate microgels in drug delivery, tissue engineering, and single cell analysis areas due to their multiple favorable properties.

Identifiers

PMID29375727
PMCPMC5762234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.